Meredith P Provost1, Kelly S Acharya1, Chaitanya R Acharya2, Jason S Yeh1, Ryan G Steward1, Jennifer L Eaton1, James M Goldfarb3, Suheil J Muasher4. 1. Division of Reproductive Endocrinology and Infertility, Duke University Medical Center, Durham, North Carolina. 2. Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, North Carolina. 3. University Hospitals Fertility Center, Beachwood, Ohio. 4. Division of Reproductive Endocrinology and Infertility, Duke University Medical Center, Durham, North Carolina. Electronic address: muashersj@gmail.com.
Abstract
OBJECTIVE: To examine the effect of recipient body mass index (BMI) on IVF outcomes in fresh donor oocyte cycles. DESIGN: Retrospective cohort study. SETTING: Not applicable. PATIENT(S): A total of 22,317 donor oocyte cycles from the 2008-2010 Society for Assisted Reproductive Technology Clinic Outcome Reporting System registry were stratified into cohorts based on World Health Organization BMI guidelines. Cycles reporting normal recipient BMI (18.5-24.9) were used as the reference group. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Implantation rate, clinical pregnancy rate (PR), pregnancy loss rate, live birth rate. RESULT(S): Success rates and adjusted odds ratios with 95% confidence intervals for all pregnancy outcomes were most favorable in cohorts of recipients with low and normal BMI, but progressively worsened as BMI increased. CONCLUSION(S): Success rates in recipient cycles are highest in those with low and normal BMI. Furthermore, there is a progressive and statistically significant worsening of outcomes in groups with higher BMI with respect to clinical pregnancy and live birth rate.
OBJECTIVE: To examine the effect of recipient body mass index (BMI) on IVF outcomes in fresh donor oocyte cycles. DESIGN: Retrospective cohort study. SETTING: Not applicable. PATIENT(S): A total of 22,317 donor oocyte cycles from the 2008-2010 Society for Assisted Reproductive Technology Clinic Outcome Reporting System registry were stratified into cohorts based on World Health Organization BMI guidelines. Cycles reporting normal recipient BMI (18.5-24.9) were used as the reference group. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Implantation rate, clinical pregnancy rate (PR), pregnancy loss rate, live birth rate. RESULT(S): Success rates and adjusted odds ratios with 95% confidence intervals for all pregnancy outcomes were most favorable in cohorts of recipients with low and normal BMI, but progressively worsened as BMI increased. CONCLUSION(S): Success rates in recipient cycles are highest in those with low and normal BMI. Furthermore, there is a progressive and statistically significant worsening of outcomes in groups with higher BMI with respect to clinical pregnancy and live birth rate.
Authors: Rashmi Kudesia; Hongyu Wu; Karen Hunter Cohn; Lei Tan; Joseph A Lee; Alan B Copperman; Piraye Yurttas Beim Journal: J Assist Reprod Genet Date: 2018-08-21 Impact factor: 3.412
Authors: Phillip A Romanski; Pietro Bortoletto; Brady Magaoay; Alice Chung; Zev Rosenwaks; Steven D Spandorfer Journal: J Assist Reprod Genet Date: 2020-11-16 Impact factor: 3.412
Authors: Jiaxin Xu; Heather S Hipp; Sarah M Capelouto; Zsolt P Nagy; Daniel B Shapiro; Jessica B Spencer; Audrey J Gaskins Journal: F S Rep Date: 2020-10-28